“We support Ms Semenya in this legal battle and look forward to a successful outcome for her. We urge the IAAF to reconsider their stance on this issue and to rely on better and more extensive research emanating from the world’s greater medical community,” said Sama chairwoman Angelique Coetzee in a statement.

Sama believed the science used by the IAAF to prop up its proposal to restrict female athletes’ testosterone levels competing in events between 400m and a mile was flawed.

“We are concerned that the arguments by the IAAF for regulating testosterone levels in such athletes are most likely based on a single, flawed study in which reporters were highly conflicted,” said Coetzee.

Testosterone is a hormone that increases muscle mass, strength and haemoglobin, which affects endurance.

Semenya has a condition called hyperandrogenism which means her testosterone levels are naturally elevated. If the IAAF gets its way Semenya would be required to take medication to reduce her testosterone levels.

The Court of Arbitration for Sport (CAS) is set to deliver its ruling on Semenya’s appeal of the IAAF proposal on March 26. (ANA)

Related Articles

JOHANNESBURG, June 17– The South African Federation of Trade Unions (Saftu) has welcomed the Competition Commission’s investigation into price fixing allegations against pharmaceutical companies following concerns raised by Advocates for Breast Cancer, the Cancer Alliance, the Cancer Association of South Africa, and Section27. “The pharmaceutical companies that are currently being investigated include Roche, which supplies […]

PARLIAMENT, January 19 (ANA) – Parliament’s ad hoc committee inquiring into the affairs of the South African Broadcasting Corporation (SABC) on Thursday turned down a request by the United Democratic Movement (UDM) that Hlaudi Motsoeneng be called to testify in the inquiry. UDM MP Nqabayomzi Kwankwa made the official request, telling MPs they could be […]

JOHANNESBURG, May 29– Group Five said on Monday that it was receiving a number of enquiries and correspondences regarding equity-based transactions following its voluntary rebuild programme (VRP). But the listed company said it was not currently in possession of a bona fide offer, of a binding or non-binding nature, for any assets of the group. […]

About Us

WeeklyXposé is an online newspaper with a mission to bring you stories that mainstream media would hesitate to bring to your screens over morning coffee. We highlight key issues plaguing our country and the world, while serving news as it happens. Every week we will bring you an Xposé, something you won't find anywhere else. Keep watching this space and coming back for more.